Biography
Mikaela Coleman is an infectious diseases and global health researcher working towards tuberculosis and leprosy elimination in the Pacific and Southern Africa. She is a research fellow affiliated with LMU University of Munich, the Health Research Unit Zimbabwe (THRU Zim) and the University of Sydney Infectious Diseases Institute (Sydney ID). Her research in the Pacific and in Sub-Saharan Africa focuses upon mixed-methods implementation research to accelerate integrated TB screening and care.
Key Impacts
TB integrated screening at the coalface of climate-change: Lessons about what works from a qualitative study with Pacific-island leaders and donors
In the Pacific, needful improvements in tuberculosis screening do not result from a lack of political will, but rather highly constrained political choices in attending to multiple competing health priorities. Integrated, multi-disease screening may reduce competition between priorities and improve screening uptake if structural barriers can be overcome.
Source: Conference 2024
Feasibility, tolerability, and yield of nasopharyngeal aspirate and stool samples for molecular TB detection in children with severe pneumonia
NPA and stool are feasible and tolerable microbiological sampling strategies in children with severe pneumonia. NPA had a higher uptake than stool when tested with Ultra, and was associated with a modest, transient discomfort/distress/pain increase for children with minimal adverse events.
Source: Conference 2024
Does TB research presented at The Union World Conference on Lung Health engage with the conditions of poverty, inequality and undernutrition experienced by TB-affected communities? An abstract review
Research presented at UNIONconf24 acknowledges the relevance of poverty to tuberculosis, but the representation of studies that engage with poverty appears suboptimal. Future qualitative analyses could give deeper insights into the engagement of UNION research with poverty, equality, and undernutrition.
Source: Conference 2024